Trial NCT00615784

View at ClinicalTrials.gov 
Org. Study IDs: UPCC 04407
Secondary IDs: UPCC 04407

Last trial update was posted on 2020-12-17

MeSH Interventions

Bexarotene

MeSH Conditions

Leukemia Leukemia, Myeloid Leukemia, Myeloid, Acute

Other Conditions

Acute Myeloid Leukemia

Stopping Reasons

Study terminated. Eisai's Targretin acquired by another pharmaceutical company.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID